HBB rs33946267: Understanding Hemoglobin D-Punjab
The HBB rs33946267 variant, commonly known as Hemoglobin D-Punjab or Hb D-Los Angeles, is a genetic change in the beta-globin gene. It is primarily associated with hemoglobinopathies when inherited alongside other hemoglobin variants, such as sickle cell trait or beta-thalassemia.
What each genotype means
Typical hemoglobin profile
This genotype represents the common, non-variant form of the HBB gene. Individuals with this profile do not carry the specific mutation associated with Hb D-Punjab.
This is the most common genotype found in the vast majority of the global population.
Hb D-Punjab carrier
You carry one copy of the HBB variant associated with Hemoglobin D-Punjab (also known as Hb D-Los Angeles). In most cases, this carrier state does not cause clinical or hematological symptoms, though you should discuss your status with a healthcare provider if you are planning a family or have concerns about hemoglobinopathies.
This variant is most prevalent in the Punjab region of Northwestern India, but it is found globally at varying frequencies.
Hb D-Punjab homozygous
This genotype indicates you carry two copies of the HBB variant associated with Hemoglobin D-Punjab. While often not associated with significant clinical symptoms, this condition can interact with other hemoglobin variants, such as Hemoglobin S, to produce more complex clinical outcomes. Please consult with a hematologist or genetic counselor to understand the implications for your health.
This is a rare genotype, occurring primarily in populations where the Hb D-Punjab variant is more common.
What is the rs33946267 Variant?
The variant rs33946267 is a single nucleotide polymorphism (SNP) located within the HBB gene, which provides instructions for making the beta-globin protein. This specific mutation involves a change in the DNA sequence (c.364G>C) that results in an amino acid substitution (Glu121Gln) in the beta-globin chain. This altered protein is referred to as Hemoglobin D-Punjab. Because it affects the structure of hemoglobin, the oxygen-carrying molecule in red blood cells, it is categorized as a hemoglobin variant. While many people who carry this variant do not experience symptoms, it is clinically significant because it can interact with other inherited blood conditions. Understanding this variant requires looking at both the specific DNA change and how it influences the overall stability and function of hemoglobin within the body.
The Role of the HBB Gene
The HBB gene is essential for the production of beta-globin, a component of adult hemoglobin (HbA). Hemoglobin is the protein in red blood cells that transports oxygen from the lungs to the rest of the body. Mutations in the HBB gene can lead to a group of disorders known as hemoglobinopathies, which include conditions like sickle cell disease and various forms of beta-thalassemia. When a variant like rs33946267 is present, the resulting hemoglobin molecule may have different physical or chemical properties compared to normal hemoglobin. In the case of Hb D-Punjab, the variant is generally considered to have a mild impact on its own. However, the gene's function is highly sensitive to mutations, and the presence of this variant can complicate the diagnosis of other blood disorders during routine clinical screening.
Clinical Associations and Evidence
Research indicates that individuals who are heterozygous for the rs33946267 variant typically do not show clinical or hematological symptoms. The clinical significance of this variant primarily emerges in cases of compound heterozygosity, where an individual inherits the Hb D-Punjab variant alongside another hemoglobin mutation, such as the sickle cell mutation (HbS) or beta-thalassemia. For example, the combination of HbS and Hb D-Punjab can lead to clinical manifestations similar to those seen in sickle cell disease. Because the evidence regarding the severity of these interactions can vary based on the specific combination of mutations, the clinical impact is often described as variable. It is important to note that this information is for educational purposes; individuals with concerns about their hemoglobin status or potential interactions should consult with a hematologist or a genetic counselor for personalized medical guidance.
Population Frequency and Distribution
The prevalence of the rs33946267 variant varies significantly across different global populations. It is notably prevalent in the Punjab region of Northwestern India, where it is one of the more common hemoglobin variants. It has also been identified in other regions, including parts of the Mediterranean and among various populations in Brazil, where it has been documented as a relatively common hemoglobin variant in certain surveys. Because it is rare in the general global population, its frequency is often studied in the context of specific ethnic or geographic groups. The uneven distribution of this variant highlights the importance of ancestry in understanding genetic risk. Researchers continue to study these patterns to better understand the evolutionary history and the clinical implications of HBB variants in diverse populations worldwide.
Managing Genetic Information
Knowing your status regarding the rs33946267 variant can be useful for understanding your carrier status for hemoglobinopathies. If you have received results indicating you carry this variant, it is important to understand that this is not a diagnosis of a disease. Instead, it provides information about your genetic makeup that may be relevant if you are planning a family or undergoing blood testing. You cannot change your genetic sequence, but you can use this information to have informed discussions with healthcare providers. If you are concerned about potential health impacts or the risk of passing this variant to children, a genetic counselor can provide context based on your specific family history and genetic profile. Always rely on professional medical advice rather than self-interpretation of genetic data when making decisions about your health.
How common is this variant?
The rs33946267 variant is rare in the general population but shows higher prevalence in specific groups, such as those from the Punjab region of India and certain Mediterranean populations.
Frequently asked questions
Is Hemoglobin D-Punjab a disease?
No, carrying the Hemoglobin D-Punjab variant is generally not considered a disease in itself. Most individuals who carry one copy of the variant are asymptomatic and live healthy lives.
What happens if I have both HbS and Hb D-Punjab?
Inheriting both the sickle cell variant (HbS) and the Hb D-Punjab variant can lead to a condition known as HbS/D-Punjab disease. The clinical symptoms of this combination can be similar to those of sickle cell disease.
Do I need special medical treatment for this variant?
Typically, no special treatment is required for carriers of the Hb D-Punjab variant. However, you should inform your doctor if you are undergoing blood tests, as this variant can sometimes affect the results of hemoglobin electrophoresis.
How is this variant detected?
This variant is typically detected through hemoglobin electrophoresis or molecular genetic testing. If you are concerned about your status, a healthcare provider can order the appropriate blood tests.
Sources & further reading
Educational information only, last refreshed 11/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs33946267?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a pathogenic mutation in the HBB gene associated with beta-thalassemia.
This variant is a pathogenic mutation in the HBB gene associated with hemoglobinopathies such as sickle cell disease.
This variant (c.20A>T, p.Glu7Val) causes the substitution of valine for glutamic acid in the beta-globin chain, leading to sickle cell trait or disease depending on zygosity.
Pathogenic variant (p.Glu6Val, HbS-Antilles) in HBB associated with sickle cell disease-like pathology.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.